See our BPC-157 Dosing Guide for detailed protocol information
Vrieling, F., Ronacher, K., Kleynhans, L., Van Den Akker, E., Walzl, G., Ottenhoff, T
KLOW is the quad-peptide version, adding KPV to the triple-peptide GLOW blend (GHK-Cu, BPC-157, TB-500)
Moreover, the BPC 157-activated bypassing key might act through modulatory effects on the prostaglandins system (i.e., counteracting non-steroidal anti-inflammatory drugs (NSAIDs) toxicity (for review, see i.e., [35]) and leaky gut syndrome (for review, see, i.e., [4]), acting also as a free radical scavenger [4,36,37,38]) and through modulatory effects on the nitric oxide (NO) system (i.e., interaction with NO agents in various models and species) [39], and in particular through special BPC 157/NO system relations (for review, see, i.e., [39])